These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 9450167)

  • 41. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
    Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. General pharmacological properties of YJA 20379-1, a novel proton pump inhibitor with antiulcer activities.
    Lee EB; Cho SI; Cheon SA; Chang MS; Kim KB; Sohn SK; Chung YK
    Arzneimittelforschung; 1999 Dec; 49(12):1018-24. PubMed ID: 10635448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. General pharmacology of insulin lispro in animals.
    Helton DR; Zimmermann JL; Heim A; Jones TW; Turk JA; Kallman MJ
    Arzneimittelforschung; 1996 Jan; 46(1):91-7. PubMed ID: 8821525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
    Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
    Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
    Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)].
    Ochiai T; Fukuchi I; Ego H; Yamamura M; Kudo Y; Ishida R
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. General pharmacology of indole [2',3':3,4]pyrido[2,1-b]quinazolinium- 5,7,8,13-tetrahydro-14-methyl-5-oxo-chloride, a new anti-dementia agent.
    Park CH; Choi SH; Kim CH; Seo JH; Koo JW; Rah JC; Kim HS; Jeong SJ; Joo WS; Lee YJ; Kim YS; Kim MS; Suh YH
    Arzneimittelforschung; 2003; 53(6):393-401. PubMed ID: 12872609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
    Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
    Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part III: Smooth muscle, gastrointestinal and miscellaneous systems.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
    Arzneimittelforschung; 1991 Jan; 41(1):25-31. PubMed ID: 1675570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. General pharmacology of nizatidine in animals.
    Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
    Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. General pharmacology studies on recombinant human follicle stimulating hormone.
    Biffoni M; Cantelmo A; Marcucci I; Martelli F; Suzuki H; Borrelli F; Suzuki K
    Arzneimittelforschung; 1994 Sep; 44(9):1096-102. PubMed ID: 7986251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. General pharmacology of recombinant human tumor necrosis factor. 1st communication: effects on cardiovascular, gastrointestinal, renal and blood functions.
    Nakatsuji K; Kii Y; Fujitani B; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):218-25. PubMed ID: 2334464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems.
    Saito T; Fukuda T; Tajima S; Sukamoto T; Yamashita A; Kanazawa T; Morimoto Y; Shimohara K; Nishimura N; Yokota K
    Arzneimittelforschung; 1988 Feb; 38(2):267-72. PubMed ID: 2897196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacological studies of a new sleep-inducer, 1H-1,2,4-triazolyl benzophenone derivative (450191-S) (V). General pharmacological activities].
    Yamamoto K; Ueda M; Kurosawa A; Hirose K; Doteuchi M; Nakamura M; Ozaki S; Matsumura S; Matsuda S; Satoh H
    Nihon Yakurigaku Zasshi; 1984 Aug; 84(2):175-212. PubMed ID: 6149178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. General pharmacology of IY-81149, a new proton pump inhibitor.
    Kim EJ; Lee RK; Lee SM; Kim DY
    Arzneimittelforschung; 2001 Jan; 51(1):51-9. PubMed ID: 11215326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. General pharmacology studies on beta-domain deleted recombinant factor VIII.
    Lee JH; Kim HW; Kwon YB; Kang MS; Choi DW; Na JH; Kwon OK; Youn HJ; Han HJ; Byun TH; Park SY; Chun BH; Pyun JH; An GH; Lee YJ; Cho MH
    Arzneimittelforschung; 2000 Jan; 50(1):86-92. PubMed ID: 10683720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.